REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,680,592 | +434.0% | 94,945 | +656.1% | 0.12% | +100.0% |
| Q1 2020 | $1,813,000 | -45.6% | 12,558 | -22.9% | 0.06% | -31.5% |
| Q4 2019 | $3,332,000 | -80.6% | 16,298 | -92.4% | 0.09% | -84.0% |
| Q3 2019 | $17,132,000 | -23.3% | 213,375 | -9.8% | 0.56% | -20.4% |
| Q2 2019 | $22,327,000 | +80.4% | 236,639 | +63.4% | 0.70% | +50.5% |
| Q1 2019 | $12,378,000 | +72.0% | 144,822 | +12.9% | 0.46% | +51.0% |
| Q4 2018 | $7,198,000 | -52.9% | 128,299 | -31.3% | 0.31% | -34.5% |
| Q3 2018 | $15,275,000 | – | 186,827 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |